- ARWR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $55.5 million.
- ARWR has traded 1.8 million shares today.
- ARWR is down 3.6% today.
- ARWR was up 11% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ARWR with the Ticky from Trade-Ideas. See the FREE profile for ARWR NOW at Trade-Ideas More details on ARWR: Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. Currently there are 5 analysts that rate Arrowhead Research a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Arrowhead Research has been 2.4 million shares per day over the past 30 days. Arrowhead Research has a market cap of $674.9 million and is part of the health care sector and drugs industry. The stock has a beta of 2.95 and a short float of 10% with 1.76 days to cover. Shares are up 19.9% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.